查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470349

先进给药系统的全球市场机会与策略（~2033）

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 358 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年先进给药系统的全球市场规模为1,922.142亿美元，到2023年复合年增长率将超过6.0%。

扩大远端医疗服务的使用

远距远端医疗服务的日益增长支持了过去一段时间先进药物输送系统市场的成长。远端医疗是一种医疗保健类型，利用通讯设备和数位平台等技术从远端位置向患者提供医疗建议、评估、治疗和追踪。将药物输送系统纳入远端医疗可以实现简单且有效率的医疗服务，确保患者即使在远离医疗服务提供者或设施的情况下也能获得正确的药物、支援和建议。根据澳洲数位健康局（负责数位处方、医疗转诊网路和我的健康记录的澳洲政府机构）的数据，2020年3月至2022年7月期间，有1.182亿人接受了远端医疗治疗服务。 95,000名医生使用远端医疗服务。因此，远端医疗服务的日益使用支持了先进给药系统市场的成长。

目录

第一章执行摘要

  • 先进的给药系统 - 市场吸引力和宏观经济条件

第二章 目录

第三章 标题列表

第四章 图表一览

第 5 章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 先进药物传输系统市场定义与细分
  • 市场区隔：按类型
    • 口服给药系统
    • 注射给药系统
    • 吸入/肺部给药系统
    • 经皮给药系统
    • 粘膜给药系统
    • 基于载体的药物传输系统
    • 其他类型
  • 市场细分：按运营商类型
    • 脂质体
    • 奈米粒子
    • 微球
    • 单株抗体
    • 其他运营商类型
  • 市场区隔：按技术
    • 前驱药物
    • 植入和子宫内避孕器
    • 靶向药物输送
    • 聚合物药物递送
    • 其他技术
  • 市场区隔：按应用
    • 肿瘤学
    • 抗感染
    • 中枢神经系统
    • 呼吸系统疾病
    • 心血管疾病
    • 肌肉骨骼疾病
    • 代谢紊乱
    • 其他用途
  • 市场区隔：按最终用户
    • 医院
    • 专科诊所
    • 其他最终用户

第七章 主要市场趋势

  • 利用先进的给药技术引进临床前药物开发
  • 利用可溶性微针增强药物传递方法的焦点
  • 用于皮下治疗的创新体内给药系统
  • 使用薄膜製剂开发先进的药物输送
  • 市场参与者之间的策略伙伴关係和协作，推动市场创新和扩张

第八章先进药物传输系统市场 - 宏观经济情景

  • COVID-19 对先进给药系统市场的影响
  • 乌克兰战争对先进给药系统市场的影响
  • 高通膨对先进给药系统市场的影响

第九章世界市场规模与成长

  • 市场规模
  • 市场成长表现（2018-2023）
    • 市场驱动因素（2018-2023）
    • 市场限制因素（2018-2023）
  • 市场成长预测（2023-2028、2033）
    • 市场驱动因素（2023-2028）
    • 市场限制因素（2023-2028）

第十章全球先进给药系统市场区隔

  • 全球先进给药系统市场：按类型分類的表现与预测（2018-2023、2028、2033）
  • 全球先进给药系统市场：按应用分類的表现与预测（2018-2023、2028、2033）
  • 全球先进给药系统市场：最终用户的表现与预测（2018-2023、2028、2033）
  • 全球先进给药系统市场：依载体类型分類的表现与预测（2018-2023、2028、2033）
  • 全球先进给药系统市场：依技术分类的表现与预测（2018-2023、2028、2033）

第十一章先进给药系统市场：区域与国家分析

  • 全球先进给药系统市场：按地区分類的表现与预测（2018-2023、2028、2033）
  • 全球先进给药系统市场：按国家/地区分類的表现和预测（2018-2023、2028、2033）

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Johnson & Johnson
    • 公司简介
    • 产品与服务
    • 商务策略
    • 财务概览
  • Baxter
    • 公司简介
    • 产品与服务
    • 商务策略
    • 财务概览
  • Becton, Dickinson and Company
    • 公司简介
    • 产品与服务
    • 商务策略
    • 财务概览
  • Medtronic Plc
    • 公司简介
    • 产品与服务
    • 商务策略
    • 财务概览
  • Pacira BioSciences, Inc.
    • 公司简介
    • 产品与服务
    • 财务概览

第二十章 其他大型创新企业

  • Abbvie, Inc.
    • 公司简介
    • 产品与服务
    • 商务策略
  • Gilead Sciences, Inc.
    • 公司简介
    • 产品与服务
    • 商务策略
  • Merck KGaA
    • 公司简介
    • 产品与服务
    • 商务策略
  • Danaher Corporation
    • 公司简介
    • 产品与服务
  • Bausch Health Companies Inc
    • 公司简介
    • 产品与服务
    • 商务策略
  • Evonik Industries AG
    • 公司简介
    • 产品与服务
    • 商务策略
  • Ypsomed Holding AG
    • 公司简介
    • 产品与服务
    • 商务策略
  • SHL Medical AG
    • 公司简介
    • 产品与服务
    • 商务策略
  • West Pharmaceutical Services, Inc
    • 公司简介
    • 产品与服务
    • 商务策略
  • Novo Nordisk A/S
    • 公司简介
    • 产品与服务
    • 商务策略
  • Purdue Pharma LP
    • 公司简介
    • 产品与服务
  • Luye Pharma Group Ltd.
    • 公司简介
    • 产品与服务
  • Ipsen Biopharmaceuticals, Inc
    • 公司简介
    • 产品与服务
    • 商务策略
  • Sun Pharmaceutical Inc
    • 公司简介
    • 产品与服务
    • 商务策略
  • Takeda Pharmaceutical Company Limited
    • 公司简介
    • 产品与服务

第21章 竞争基准化分析

第22章竞争对手仪表板

第二十三章 重大併购

  • Cordis Corporation Acquired MedAlliance SA
  • DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
  • LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
  • SHL Medical Acquired LCA Automation AG
  • Halozyme Therapeutics Inc Acquired Antares Pharma Inc
  • Nemera Acquired Copernicus

第24章机会与策略

  • 2028 年全球先进给药系统市场 - 提供最多新机会的国家
  • 2028 年全球先进给药系统市场 - 提供最多新机会的细分市场
  • 2028 年全球先进给药系统市场 - 成长策略
    • 基于市场趋势的策略
    • 竞争策略

第25章先进药物传输系统市场：结论与建议

  • 结论
  • 建议
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第26章附录

简介目录
Product Code: o&s1094

Advanced drug delivery systems (ADDS) refer to innovative and sophisticated techniques or technologies designed to enhance the delivery of therapeutic agents (drugs) to specific target sites in the body. ADDS encompass a broad range of approaches, including formulations, carriers and strategies that aim to improve the efficacy, safety and patient compliance of drug delivery.

The advanced drug delivery systems market consists of sales, by entities (organizations, partnerships and sole proprietors), of advanced drug delivery systems that include technologies and methodologies to deliver drugs to specific parts of the body in a controlled manner.

The global advanced drug delivery systems market was valued at $192,214.2 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Growing Use Of Telemedicine Services

The growing use of telemedicine services supported the growth of the advanced drug delivery systems market during the historic period. Telemedicine is a type of healthcare that involves the use of technology, namely telecommunication equipment and digital platforms, to provide healthcare advice, evaluation, therapy and follow-up to patients remotely. Incorporating drug delivery systems with telemedicine facilitates simple and efficient healthcare delivery, assuring patients receive appropriate drugs, support and advice, even if they are geographically separated from healthcare practitioners or facilities. According to the Australian Digital Health Agency, an Australia-based government organization in charge of digital prescriptions, medical referral networks and My Health Record, 118.2 million telehealth therapy services were offered to 18 million people between March 2020 and July 2022, and more than 95,000 practitioners employ telehealth services. Therefore, the growing use of telemedicine services supported the growth of the advanced drug delivery systems market.

Introducing Preclinical Drug Development With Advanced Drug Delivery Technology

Companies are introducing preclinical drug development with advanced drug delivery technology (EUDRACAP) to accelerate innovation, unlock value and improve quality in the preclinical development stage. This is used to enhance preclinical drug development by offering functional, ready-to-fill oral capsules. These capsules simplify the drug development process, reduce time and variables and safeguard the active ingredient to optimize absorption rates and prevent premature degradation. For example, in October 2023, Evonik, a German-based specialty chemicals company, launched an advanced drug delivery system, called EUDRACAP preclinic enteric, a functional oral capsule designed for use in preclinical trials. This capsule is a very small, 9-h (5.1 mm) technical-grade capsule, suitable for passing through the gastrointestinal tract of preclinical subjects. The capsule simplifies drug development by reducing time, cost and variables and leverages EUDRAGIT(R) functional coatings for optimized release profiles, while offering custom options for specific active pharmaceutical ingredient (API), formulation and brand requirements and a seamless transition from preclinical to clinical and commercial stages, with support for custom capsule coatings, formulation development and current good manufacturing practice (cGMP) scale-up.

The global advanced drug delivery systems market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 2.91% of the total market in 2022.

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global advanced drug delivery systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies based on local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider advanced drug delivery systems market; and compares it with other markets.

The report covers the following chapters:

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by carrier type, by technology, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the advanced drug delivery systems market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by carrier type, by technology, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section includes recommendations for advanced drug delivery systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System And Other Types
  • 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
  • 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
  • 4) By Application: Oncology; Anti-Infective; Central Nervous System; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications
  • 5) 4) By End User: Hospitals; Specialized Clinics; Other End Users
  • Companies Mentioned: Johnson & Johnson, Inc; Baxter; Becton, Dickinson And Company; Medtronic Plc; Pacira Biosciences, Inc
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; advanced drug delivery systems indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Advanced Drug Delivery Systems - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Advanced Drug Delivery Systems Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Oral Drug Delivery System
    • 6.4.2 Injection-Based Drug Delivery System
    • 6.4.3 Inhalation/Pulmonary Drug Delivery System
    • 6.4.4 Transdermal Drug Delivery System
    • 6.4.5 Transmucosal Drug Delivery System
    • 6.4.6 Carrier-Based Drug Delivery System
    • 6.4.7 Other Types
  • 6.5 Market Segmentation By Carrier Type
    • 6.5.1 Liposomes
    • 6.5.2 Nanoparticles
    • 6.5.3 Microspheres
    • 6.5.4 Monoclonal Antibodies
    • 6.5.5 Other Carrier Types
  • 6.6 Market Segmentation By Technology
    • 6.6.1 Prodrug
    • 6.6.2 Implants And Intrauterine Devices
    • 6.6.3 Targeted Drug Delivery
    • 6.6.4 Polymeric Drug Delivery
    • 6.6.5 Other Technologies
  • 6.7 Market Segmentation By Application
    • 6.7.1 Oncology
    • 6.7.2 Anti-Infective
    • 6.7.3 Central Nervous System
    • 6.7.4 Respiratory Diseases
    • 6.7.5 Cardiovascular Diseases
    • 6.7.6 Musculoskeletal Disorders
    • 6.7.7 Metabolic Disorders
    • 6.7.8 Other Application
  • 6.8 Market Segmentation By End User
    • 6.8.1 Hospitals
    • 6.8.2 Specialized Clinics
    • 6.8.3 Other End Users

7 Major Market Trends

  • 7.1 Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
  • 7.2 Increasing Focus Dissolving Microneedle Drug Delivery Methods
  • 7.3 Innovative On-Body Delivery Systems For Subcutaneous Therapies
  • 7.4 Pioneering Advanced Drug Delivery With Thin Film Formulation
  • 7.5 Strategic Partnerships And collaborations Among Market Players To Drive Innovation and Expansion In The Market

8 Advanced Drug Delivery Systems Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Advanced Drug Delivery Systems Market
  • 8.2 Impact Of The War In Ukraine On The Advanced Drug Delivery Systems Market
  • 8.3 Impact Of High Inflation On The Advanced Drug Delivery Systems Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Advanced Drug Delivery Systems Market Segmentation

  • 10.1 Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Advanced Drug Delivery Systems Market, Regional and Country Analysis

  • 11.1 Global Advanced Drug Delivery Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Advanced Drug Delivery Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Advanced Drug Delivery Systems Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.1 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.2 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Advanced Drug Delivery Systems Market: Country Analysis
  • 13.5 UK Market
  • 13.6 UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.7 UK Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 Germany Market
  • 13.10 Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 France Market
  • 13.14 France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 Italy Market
  • 13.18 Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Spain Market
  • 13.22 Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Advanced Drug Delivery Systems Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Advanced Drug Delivery Systems Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Advanced Drug Delivery Systems Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

  • 19.1 Company Profile
  • 19.2 Johnson & Johnson
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial overview
  • 19.3 Baxter
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Becton, Dickinson and Company
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Medtronic Plc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Pacira BioSciences, Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Advanced Drug Delivery Systems Market Other Major And Innovative Companies

  • 20.1 Abbvie, Inc.
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
    • 20.1.3 Business Strategy
  • 20.2 Gilead Sciences, Inc.
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
    • 20.2.3 Business Strategy
  • 20.3 Merck KGaA
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
    • 20.3.3 Business Strategy
  • 20.4 Danaher Corporation
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Bausch Health Companies Inc
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
    • 20.5.3 Business Strategy
  • 20.6 Evonik Industries AG
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
    • 20.6.3 Business Strategy
  • 20.7 Ypsomed Holding AG
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
    • 20.7.3 Business Strategy
  • 20.8 SHL Medical AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
    • 20.8.3 Business Strategy
  • 20.9 West Pharmaceutical Services, Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
    • 20.9.3 Business Strategy
  • 20.10 Novo Nordisk A/S
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
    • 20.10.3 Business Strategy
  • 20.11 Purdue Pharma LP
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Luye Pharma Group Ltd.
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Ipsen Biopharmaceuticals, Inc
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
    • 20.13.3 Business Strategy
  • 20.14 Sun Pharmaceutical Inc
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
    • 20.14.3 Business Strategy
  • 20.15 Takeda Pharmaceutical Company Limited
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Cordis Corporation Acquired MedAlliance SA
  • 23.2 DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
  • 23.3 LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
  • 23.4 SHL Medical Acquired LCA Automation AG
  • 23.5 Halozyme Therapeutics Inc Acquired Antares Pharma Inc
  • 23.6 Nemera Acquired Copernicus

24 Opportunities And Strategies

  • 24.1 Global Advanced Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Advanced Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Advanced Drug Delivery Systems Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Advanced Drug Delivery Systems Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer